Javascript must be enabled to continue!
P3382Vascular calcium Index: an imaging tool to predict vascular complications and major bleeding in TF-TAVI
View through CrossRef
Abstract
Introduction
Vascular calcification has been associated with worse outcomes in transfemoral TAVI (TF-TAVI). However, there is currently no simple method to assess it and identify different patterns of calcification in an objective and quantitative manner. The purpose of this study was to develop a quantitative score of aortic (Ao) and ileofemural (IF) calcification and to assess its ability to predict life-threatening bleeding (LTB) and major vascular complications during TF-TAVI.
Methods
Case-control single center retrospective study of patients undergoing TF-TAVI between Nov2015 and Aug2018 including 183 consecutive patients (99 women, mean age 83±3 years, mean Euroscore II - ESII - 6.0±4.1). The Vascular Calcium Score was calculated for the entire Ao and IF vessels using a modified Agatston score derived from contrast-enhanced CT images, with calcium threshold locally adjusted for luminal attenuation (mean attenuation + 5x SD). A luminal attenuation threshold >600UH impaired vascular calcium evaluation and patients were excluded. LTB and major vascular complications were adjudicated according to the VARC-2 classification and identified by chart review by and independent team.
Results
Thirty patients (16%) suffered major bleeding and 13 (7%) experienced LTB. Major vascular injury occurred in 11 patients (6%). The median total vascular calcium score (TCS) was 11752 AU (IQR: 6388–19844) and median IF score (IFS) was 2210AU (IQR: 865–4170). TCS indexed for body surface area (TCSi) was predictor of LTB (AUC: 0.78±0.07, p<0.05) and of major vascular complications (AUC: 0.85±0.05, p<0.05). After multivariate analysis, iTCS and glomerular filtration rate (GFR) remained as predictors of LTB with an HR of 1.11 for each increase in 1000UA/m2 of TCSi (95% CI: 1.03–1.18) and 0.94 (95% CI: 0.88–0.985) respectively, independently of the ESII. iTCS and GFR were also independently associated with major vascular complications (p<0.05). Patients with an iTCS above 9750AU/m2 have an odds ratio of 7.7 (95% CI: 2.0 - 29.2) for LTB. This cut-off has a sensitivity of 77% and a specificity of 70% for LTB. Similarly, patients with an iTCS above 9750AU/m2 have an odds ratio of 10.3 (95% CI: 22 - 49.3) for major vascular injury.
Conclusions
A quantitative score for vascular calcification in contrast-enhanced CT images was developed. iTCS was independently associated with life-threatening bleeding and major vascular complications.
Oxford University Press (OUP)
Title: P3382Vascular calcium Index: an imaging tool to predict vascular complications and major bleeding in TF-TAVI
Description:
Abstract
Introduction
Vascular calcification has been associated with worse outcomes in transfemoral TAVI (TF-TAVI).
However, there is currently no simple method to assess it and identify different patterns of calcification in an objective and quantitative manner.
The purpose of this study was to develop a quantitative score of aortic (Ao) and ileofemural (IF) calcification and to assess its ability to predict life-threatening bleeding (LTB) and major vascular complications during TF-TAVI.
Methods
Case-control single center retrospective study of patients undergoing TF-TAVI between Nov2015 and Aug2018 including 183 consecutive patients (99 women, mean age 83±3 years, mean Euroscore II - ESII - 6.
0±4.
1).
The Vascular Calcium Score was calculated for the entire Ao and IF vessels using a modified Agatston score derived from contrast-enhanced CT images, with calcium threshold locally adjusted for luminal attenuation (mean attenuation + 5x SD).
A luminal attenuation threshold >600UH impaired vascular calcium evaluation and patients were excluded.
LTB and major vascular complications were adjudicated according to the VARC-2 classification and identified by chart review by and independent team.
Results
Thirty patients (16%) suffered major bleeding and 13 (7%) experienced LTB.
Major vascular injury occurred in 11 patients (6%).
The median total vascular calcium score (TCS) was 11752 AU (IQR: 6388–19844) and median IF score (IFS) was 2210AU (IQR: 865–4170).
TCS indexed for body surface area (TCSi) was predictor of LTB (AUC: 0.
78±0.
07, p<0.
05) and of major vascular complications (AUC: 0.
85±0.
05, p<0.
05).
After multivariate analysis, iTCS and glomerular filtration rate (GFR) remained as predictors of LTB with an HR of 1.
11 for each increase in 1000UA/m2 of TCSi (95% CI: 1.
03–1.
18) and 0.
94 (95% CI: 0.
88–0.
985) respectively, independently of the ESII.
iTCS and GFR were also independently associated with major vascular complications (p<0.
05).
Patients with an iTCS above 9750AU/m2 have an odds ratio of 7.
7 (95% CI: 2.
0 - 29.
2) for LTB.
This cut-off has a sensitivity of 77% and a specificity of 70% for LTB.
Similarly, patients with an iTCS above 9750AU/m2 have an odds ratio of 10.
3 (95% CI: 22 - 49.
3) for major vascular injury.
Conclusions
A quantitative score for vascular calcification in contrast-enhanced CT images was developed.
iTCS was independently associated with life-threatening bleeding and major vascular complications.
Related Results
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Transcatheter aortic valve implantation in degenerated trans-catheter and surgical bioprosthetic aortic valve
Abstract
Background
The moving forward indication of transcatheter aortic valve implantation (TAVI) to younger aortic valve sten...
Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis
Objective
The effect of postoperative blood flow status on the prognosis of patients with low-gradient severe aortic stenosis (AS) has not been examined. Severe A...
Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI
Predisposing and precipitating factors of post-operative delirium after transfemoral TAVI
Abstract
Background
Transcatheter aortic valve implantation (TAVI) represents the treatment of choice for aortic stenosis (AS) p...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Predictors of futility outcomes after TAVI: insights from the France TAVI Registry
Predictors of futility outcomes after TAVI: insights from the France TAVI Registry
Abstract
Background
Transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of aortic stenosis and provi...
PRIORiTize-TAVI score: a novel clinical tool Predicting moRtalIty Or uRgent TAVI on waiting list
PRIORiTize-TAVI score: a novel clinical tool Predicting moRtalIty Or uRgent TAVI on waiting list
Abstract
Background
Waiting list (WL) for transcatheter aortic valve implantation (TAVI) has been increasing and prioritization ...
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Bleeding Risk Factors in Thrombocytopenic Patients with Hematologic Malignancies
Introduction
Despite prophylactic platelet transfusions, World Health Organization (WHO) grade ≥ 2 bleeding occurs in 50 to 70% of patients with hematologic malignan...
P3698Long-term durability of transcatheter aortic valve prostheses: results of a center
P3698Long-term durability of transcatheter aortic valve prostheses: results of a center
Abstract
The durability of transcatheter heart valves and long-term clinical outcomes are unknown. The aim of this study was to...


